Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 19.74%
December 31, 2025 11.72%
September 30, 2025 25.26%
June 30, 2025 6.84%
March 31, 2025 18.81%
December 31, 2024 12.15%
September 30, 2024 16.56%
June 30, 2024 10.56%
March 31, 2024 4.58%
December 31, 2023 3.97%
September 30, 2023 -5.15%
June 30, 2023 35.77%
March 31, 2023 12.36%
December 31, 2022 24.39%
September 30, 2022 10.85%
June 30, 2022 16.82%
March 31, 2022 4.99%
December 31, 2021 9.09%
September 30, 2021 10.65%
June 30, 2021 8.29%
March 31, 2021 18.15%
December 31, 2020 4.08%
September 30, 2020 13.48%
June 30, 2020 22.89%
March 31, 2020 14.26%
Date Value
December 31, 2019 15.69%
September 30, 2019 15.25%
June 30, 2019 12.68%
March 31, 2019 10.68%
December 31, 2018 18.42%
September 30, 2018 19.51%
June 30, 2018 2.69%
March 31, 2018 8.74%
December 31, 2017 6.20%
September 30, 2017 12.17%
June 30, 2017 12.83%
March 31, 2017 10.62%
December 31, 2016 68.17%
September 30, 2016 5.60%
June 30, 2016 4.01%
March 31, 2016 9.54%
December 31, 2015 9.20%
September 30, 2015 -3.05%
June 30, 2015 1.79%
March 31, 2015 -2.35%
December 31, 2014 -7.24%
September 30, 2014 -6.98%
June 30, 2014 0.87%
March 31, 2014 -14.89%
December 31, 2013 -12.80%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
AngioDynamics, Inc. -13.17%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 4.56%